Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YEAR 3 - SEMESTER 2 > CASE 5 - Dementia > Flashcards

CASE 5 - Dementia Flashcards

1
Q

Name 2 categories of the etiology of dementia

A

Neurodegenerative

Additional causes (e.g. cerebrovascular disease, hypoxia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the most common neurodegenerative cause of dementia

A

Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does dementia usually present clinically?

A

A spouse or family member brings to attention the memory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cognitive functions tend to DECLINE with age and which tend to IMPROVE?

A

IMPROVE: word knowledge

DECLINE: speed of processing, working memory, long-term memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the definition of dementia?

A

A group of diseases characterised by declines in cognition, function, and behaviour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the number one risk factor for dementia?

A

AGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What percentage of cases of Alzheimer’s disease are sporadic vs. familial?

A

SPORADIC: 95%

FAMILIAL: 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the characteristics of the EARLY stage of Alzheimer’s disease and how long this usually lasts.

A

EARLY STAGE: 2-4 years.

(often not noticed by family and friends)

  • Frequently forgetting or misplacing items
  • Getting lost easily
  • Need reminder for daily activities
  • Word finding problems
  • Repeated questions
  • Loss of interest in previously enjoyable activities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the characteristics of the MIDDLE stage of Alzheimer’s disease and how long this usually lasts.

A

MIDDLE STAGE: 2-10 years.

(usually obvious to family and friends)

  • Wandering, disruptive behaviours
  • Sundowning
  • Require constant supervision
  • Persistent and pervasive memory loss
  • Delusions
  • Disrupted sleep
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the characteristics of the LATE stage of Alzheimer’s disease and how long this usually lasts.

A

LATE STAGE: 1-3 years

  • Withdrawn, with extreme mood & behavioural problems
  • Cannot speak or understand language
  • Bedbound, chair bound, unable to walk
  • Cannot recognise even the closest family members
  • Brain loses the ability to control the body
  • Difficulty swallowing (pneumonia is common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the life expectancy of someone who has been diagnosed with Alzheimer’s disease?

A

Life expectancy after diagnosis = 3 - 20 years.

Average is 8 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 3 GENETIC MUTATIONS that increase risk of familial Alzheimer’s

A

Genes affected:

  • APP
  • Presenilin1 (most common)
  • Presenilin2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name 2 RISK MODIFIER/SUSCEPTIBILITY GENES that increase the risk of developing Alzheimer’s

A
  • ApoE gene: possessing 1 or more copies of ApoE4 markedly increases risk
  • A2M gene
    https: //www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-genes/art-20046552
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name 5 health conditions/lifestyle factors that are risk factors for Alzheimer’s disease

A
  • Cerebrovascular disease
  • Smoking
  • Obesity
  • HTN
  • T2DM
  • Traumatic head injury
  • Alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the brain changes that occur in late-stage Alzheimer’s disease

A

BRAIN ATROPHY:

  • Enlargement of the ventricles
  • Enlargement of sulci
  • Shrinkage of cerebral cortex
  • Shrinkage of hippocampus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which ApoE allele puts you most at risk of developing Alzheimer’s disease?

How is this allele inherited?

A

ApoE on chromosome 19: one copy from your mother, one copy from your father.

If you inherit 2 COPIES of ApoE4, you have a 19-fold increased risk of developing AD compared to someone who inherits 2 copies of ApoE3.

https://www.youtube.com/watch?v=v5gdH_Hydes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the 3 pathophysiological mechanisms that contribute to Alzheimer Disease

A
  • SENILE / NEURITIC PLAQUES: Amyloid Plaques (extracellular / outside neurons)
  • NEUROFIBRILLARY TANGLES: Tau tangles (intracellular - tau is a component of microtubules)
  • Acetylcholine deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do beta-amyloid plaques affect brain function?

A
  1. Beta-amyloid plaques are STICKY and can form clumps that get between neurons, disruption neuron-neuron signalling
  2. They may also be pro-inflammatory –> inflammation damages surrounding neurons
  3. They can deposit in blood vessels and increase the risk of haemorrhage
    https: //www.youtube.com/watch?v=v5gdH_Hydes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do tau tangles disrupt neuronal function? Outline the pathophysiology.

A

Tau holds together the microtubules found in axons.

  1. It is thought that beta-amyloid plaques initiate KINASE activation, transferring phosphate to the tau protein.
  2. Phosphate causes the tau proteins to break away from microtubules and form clumps/tangles
  3. The phosphorylated tau tangles disrupt neuronal signalling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the first feature of Alzheimer Disease?

A

Memory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Outline the DSM-5 criteria for dementia

A
  1. Significant cognitive decline in at least one of the following domains:
    - Learning and memory
    - Language
    - Executive function
    - Complex attention
    - Perceptual-motor
    - Social cognition
  2. Cognitive deficits interfere with everyday life, patient becomes dependent on help with complex activities (e.g., paying bills)
  3. Cognitive deficits do not occur exclusively in the context of a delirium
  4. Cognitive deficits are not better explained by another mental disorder (e.g., major depression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is assessed by the MMSE?

What is the cutoff for dementia?

A

Degree of cognitive impairment in individuals with suspected dementia

A patient with an MMSE score of <24 is generally considered to have dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List the MMSE categories for mild, moderate, and severe dementia

A

MILD DEMENTIA: 21-24 points

MODERATE DEMENTIA: 10 - 20 points

ADVANCED DEMENTIA: <10 points

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Name the 5 components of diagnosing dementia

A
  1. Full medical history (including drugs & alcohol)
  2. History of progressive cognitive decline
  3. Physical exam
  4. Investigations
  5. Validated cognitive assessment tool
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How many Australians over the age of 65 have dementia?

A

1 in 10 Australians over the age of 65 have dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Name 5 potentially modifiable risk factors for dementia

A 
Air pollution (including second-hand smoke exposure)
Hazardous alcohol consumption
Depression
Diabetes
Poor education
Head injury
Hearing impairment
Hypertension
Obesity
Physical inactivity
Smoking
Social isolation.

(identified by a Lancet commission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Name 5 lifestyle factors that can be protective against dementia

A
  • Regular physical activity
  • Smoking cessation
  • Remain cognitively and socially active
  • Eat a healthy diet
  • Protect against head trauma (e.g. wearing a helmet while cycling)
  • Reduce alcohol intake
  • Prevent hearing loss
  • Practice good sleep hygiene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The use of certain drugs in later life may increase dementia risk. Name these 3 drugs

A
  • Antihistamines
  • Anticholinergics
  • Benzodiazepines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Dementia is diagnosed when…

2 facets

A
  1. Cognitive decline affects a person’s ability to function independently
  2. This decline is not attributable to another reversible cause (e.g. depression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Some causes of cognitive impairment are reversible and should be excluded before a diagnosis of dementia is made. For each of the following investigations, state what underlying cause is being looked for:

  1. CBE
  2. BUN, calcium, creatinine, electrolytes
  3. LFTs
  4. TFTs
  5. BGL
  6. B12 & folate
A
  1. CBE: rule out anaemia and infection
  2. BUN, calcium, creatinine, electrolytes: rule out metabolic disturbances & organ failure
  3. LFTs: just see if it’s abnormal lol
  4. TFTs: rule out hypo/hyperthyroidism
  5. BGL: rule out hypo/hyperglycaemia
  6. B12 & folate: rule out deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Patients with dementia symptoms who are at risk of STI should also receive which investigations? Why?

A
  • Syphilis serology
  • HIV antibody-antigen testing

Symptoms may be due to neurosyphilis or dementia may be associated with HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Many cognitive tests exist to assist with the diagnosis of dementia. How do clinicians choose which test to use?

A

Choice of test depends on PATIENT FACTORS (e.g. linguistic ability, motor and verbal skills, age, education) and CLINICIAN EXPERIENCE

https://tgldcdp-tg-org-au.proxy.library.adelaide.edu.au/viewTopic?topicfile=dementia&guidelineName=Psychotropic&topicNavigation=navigateTopic#toc_d1e1702

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Name 5 dementia subtypes, in order of prevalence

A
  1. Alzheimer Disease (50-75%)
  2. Vascular dementia (20-30%)
  3. Frontotemporal dementia (up to 10%)
  4. Dementia with Lewy bodies & Parkinson disease dementia (up to 10%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

> 90% of patients will also experience behavioural and psychological symptoms of dementia (BPSD), in addition to memory loss.

Name 3 examples of BPSD

A
  • Hallucinations
  • Delusions (distressing beliefs)
  • Agitation
  • Depression
  • Anxiety
  • Apathy
  • Disinhibition
  • Night-time behaviours (waking up and getting up at night)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Which dementia subtype is most commonly associated with memory impairment EARLY ON in the disease?

A

Alzheimer dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Unless there is a clear diagnosis of mild-moderate dementia, which type of imaging should also be ordered?

A

Head CT, MRI, or PET scan to exclude other NEUROPATHOLOGIES and also determine dementia SUBTYPE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

List the characteristic order of LANGUAGE impairment in Alzheimer Disease

A

Naming –> comprehension –> fluency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Loss of insight is seen in which dementia subtype?

A

Frontotemporal dementia

but is also common in AD

39
Q

How can Alzheimer Disease be differentiated from age-related memory loss on History?

A

Ageing: INDEPENDENCE is preserved. Episodic and working memory are affected first, with preservation of semantic and procedural memory.

Alzheimer Disease: short-term memory loss and loss of episodic memory.

40
Q

Familial AD results in _______ onset of the disease and ______ progression.

A

Familial AD results in EARLIER onset of the disease and RAPID progression.

41
Q

What is the significance of grasp reflexes in adults?

A

Signifies frontal lobe damage

42
Q

The presence of a tremor may suggest which causes of DEMENTIA?

A

Parkinson Disease
Frontotemporal Dementia
Huntington Disease

43
Q

Romberg test

A

.

44
Q

Describe the Parkinsonian gait

A

PARKINSONIAN SHUFFLING GAIT

  • Feet land flat on the floor, instead of on the heel
  • Festation/shuffling (quick, small, involuntary steps forward)
  • Retropulsion (quick, small, involuntary steps back)
  • Propulsion: forward-learning gait
  • Decreased arm swing
45
Q

Cogwheel rigidity is a feature of which type of dementia?

Describe this sign.

A

Parkinson disease

Cogwheel rigidity: a tremor inlaid within increased muscle tonus/rigidity. Can manifest BEFORE a tremor.

46
Q

Name 5 clinical features of vitamin B12 deficiency

A
  • Signs of anaemia (e.g. pallor) and jaundice
  • Neuropsychiatric disease (e.g. depression, dementia)
  • Glossitis
  • Worsening vision
  • Loss of autonomic function (impotence, incontinence)
  • Neurological deficits: loss of sensation, proprioception, gait abnormalities, spastic paralysis
47
Q

Which types of memory loss occurs FIRST in AD?

A

Episodic memory

Short-term memory

48
Q

What is PARKINSONISM and how does it differ from PARKINSON DISEASE?

A

Parkinsonism is a clinical SYNDROME presenting with these 4 features:

  1. Rigidity
  2. Rest tremor
  3. Bradykinesia
  4. Postural instability

Parkinson Disease is a neurodegenerative disease which MOST COMMONLY causes Parkinsonism.

49
Q

Which neurons are depleted in Parkinson Disease?

A

Dopaminergic neurons in the substantia nigra of the basal ganglia are depleted in PD

50
Q

How is Parkinson Disease Dementia (PDD) differentiated from Dementia with Lewy Bodies (DLB)?

A

Parkinson Disease Dementia = dementia occurs after a well-established history of Parkinsonism for >1 YEAR after the onset of motor symptoms

DEMENTIA w/ LEWY BODIES = dementia usually occurs WITH or BEFORE the development of parkinsonian signs, or no more than a year after onset of motor symptoms

https://www.amboss.com/us/knowledge/Parkinson-plus_syndromes#Z1fbf2126dd4b0d719afbb860d583d62f

51
Q

Remember that many patients that have Lewy body dementia also show brain changes that are characteristic of AD. The DOMINANT change is the one used to guide diagnosis.

A

.

52
Q

Name the 4 cardinal features of Parkinsonism (TRAP)

A
  1. Tremors
  2. Rigidity
  3. Decrementing bradykinesia (/Akinesia)
  4. Postural instability
53
Q

Other than the 4 cardinal features of Parkinsonism, name 2 symptoms from each of the following categories:

  1. CRANIOFACIAL
  2. VISUAL
  3. GAIT
A
  1. CRANIOFACIAL: hypomimia, hypophonia, dysphagia
  2. VISUAL: blurred vision, eyelid opening apraxia
  3. GAIT: shuffling, freezing, festination
54
Q

Destruction of the basal ganglia is responsible for many of the symptoms of Parkinson Disease. Explain the reason for this.

A

The basal ganglia plays an INHIBITORY role in motor movement, working to eliminate antagonistic or unnecessary movement.

When the dopaminergic neurons in the basal ganglia are destroyed, these inhibitory effects cannot be carried out. This results in:

  • Increased muscle tone (rigidity)
  • Unnecessary/unwanted movements (tremors)
  • Slowness in initiating new movement
55
Q

What is the typical age of onset of Parkinson Disease?

A

~60 years (though genetic forms tend to manifest earlier)

56
Q

The preclinical phase of Parkinson Disease can be preceded by which 4 symptoms?

A
  1. Anosmia
  2. Constipation
  3. Mood disorders (e.g. depression, anxiety, apathy)
  4. Sleep disturbances (e.g. REM sleep disorder, restless leg syndrome, excessive daytime sleepiness)
57
Q

How is Parkinson Disease diagnosed?

A

CLINICALLY

58
Q

Motor signs in Parkinson Disease are usually distributed…

A

Unilaterally (but can progress to the contralateral side) & asymmetrically (more pronounced on one side)

59
Q

What is the froment manoeuvre?

A

The patient is asked to perform repetitive movements (e.g. tapping their hand) in the contralateral extremity to make subclinical rigidity more pronounced

60
Q

Describe what you might find on general inspection of a patient with Parkinson Disease

A
  • Stooped posture
  • Resting tremor
  • Rigidity
  • Flexed elbows and wrists
  • Hypomimia
61
Q

Name 3 NON-MOTOR features of Parkinson Disease

A
  1. AUTONOMIC SYMPTOMS (postural hypotension, urinary urgency, oily skin, impaired sexual function)
  2. NEUROPSYCHIATRIC: anxiety, depression, apathy, cognitive deficits
  3. DISORDERED SLEEP

Other: anosmia, hypomimia

62
Q

What is the first-line pharmacological management of Parkinson Disease?

A

LEVODOPA + either BENSERAZIDE or CARBIDOPA

LEVODOPA = dopamine precursor

BENSERAZIDE & CARBIDOPA are peripheral decarboxylase inhibitors that prevent PERIPHERAL conversion of levodopa to dopamine. They do not cross the BBB, so levodopa can still be metabolised to dopamine where it’s needed.

63
Q

What is MILD COGNITIVE IMPAIRMENT (MCI)?

A

Mild cognitive impairment is generally accepted as the state prior to developing clinical dementia, where ST memory problems may evolve. 15% of patients with MCI go on to develop Alzheimer Disease.

64
Q

Give 2 examples of (non-dementia) conditions which can cause MCI.

A
  • Depression (i.e. pseudodementia)

- Vascular disease

65
Q

Name 2 situations in which CSF biomarkers can be used in dementia diagnosis

A

When there is clinical suspicion of certain conditions:

  1. EXCLUSION of certain diseases (e.g. VZV, HSV, HIV syphilis)
  2. ATYPICAL clinical presentations of AD
66
Q

Which drug class is used for pharmacological management of Alzheimer disease?

A

Acetlycholinesterase inhibitors

67
Q

Name the 3 first-line pharmacological treatments of Alzheimer Disease

When can you consider increasing the dosages?

A
  1. Donepezil
  2. Galantamine
  3. Rivastigmine (transdermal patch)

Doses can be increased after 4 weeks if the patients are tolerating it well. Adverse effects are dose-dependent, which is why you start with a low dose and slowly increase.

68
Q

What drug can be added (or used instead of acetylcholinesterase inhibitors) in patients with moderate - severe dementia?

A

Memantine (NDMA receptor antagonist)

For those with an MMSE of 10-14

69
Q

What are the adverse effects of acetylcholinesterase inhibitors?

A

Significant GI effects (NV, diarrhoea, anorexia)

Weight loss, vivid dreams, urinary incontinence, tremor, etc.

70
Q

Which 3 tests must be performed before commencing acetylcholinesterase inhibitors?

A
  • Weight
  • ECG
  • Falls risk
71
Q

Acetylcholinesterase inhibitors can only be prescribed for patients with an MMSE ABOVE…?

A

10

72
Q

When and what type of neuroimaging is ordered in dementia?

A

CT head is ordered for most people

Geriatrician will order an MRI for some

73
Q

How can you differentiate between someone with mild cognitive impairment (MCI) and early dementia?

A

Those with only MCI will retain their independence

74
Q

The ApoE2 gene has what function in Alzheimer Disease?

A

It is PROTECTIVE

75
Q

For how long are the Alzheimer drugs beneficial?

A

6-7 months

Beyond that, there is no benefit. Only adverse effects

76
Q

Do acetylcholinesterase inhibitors slow the progression of disease?

A

NO - they only offer symptom improvement

77
Q

Why is it important for a therapeutic trial of acetylcholinesterase inhibitors to be carried out?

A
  • Not everyone responds to them
  • Those who do respond can show clinically-significant improvement
  • An MMSE score improvement of 2 or more is required for them to be funded by the PBS
78
Q

Can a patient continue receiving subsidised acetylcholinesterases beyond the first 6 months?

A

YES - if they demonstrate a clinically-significant response (MMSE +2 points, or improved quality of life)

The GP must obtain approval by phone and re-assess every 6 months

79
Q

What is the Montreal Cognitive Assessment (MoCA), and what does it involve?

A

MoCA = a screening tool that assesses cognitive impairment. Scored /30.

Involves visuospatial function, naming, memory, attention, etc. (the one with the 3 animals)

80
Q

Describe the Rowland University Dementia Awareness Scale (RUDAS) and its benefits.

A

Tests visuospatial ability, memory, praxis, language, etc.

Beneficial in patients whose first language is not English (does not rely on linguistic ability as much).

81
Q

Name 4 cons of the MMSE

A
  • Lacks clinical specificity
  • Insensitive to patients with MCI
  • Does not take into account things like education level, linguistic ability
  • High measurement error limits its ability to document change over time
82
Q

What is the MOA of donepezil?

A

Decreases breakdown of acetylcholine, reducing the apparent deficiency of cholinergic NT activity in Alzheimer’s disease.

83
Q

What is the MOA of memantine?

A

NDMA antagonist

May reduce glutamate-induced neuronal degradation. Alzheimer’s disease is thought to be associated with excess glutamate.

84
Q

Do patients with dementia retain the ability to drive?

A

Most patients with dementia lost the ability to drive within a few years of diagnosis

85
Q

Name 3 strategies for minimising the impact of cognitive decline on the daily life of a patient with dementia

A
  • Determine and address unmet needs (e.g. organise help w/complex ADLs)
  • Deprescribe drugs that could exacerbate cognitive impairment
  • Webster pack if needed
  • Review driving ability
86
Q

How can the BPSD of dementia be managed?

A
  • Identify triggers, optimise non-pharm interventions

- Dementia Behaviour Management Advisory Service (DBMAS) has a 24-hour helpline

87
Q

List 3 non-pharmacological measures of managing dementia

A
  • Healthy lifestyle (E.g. sleep, reduce alcohol, smoking cessation, healthy living, remain cognitively and socially active)
  • Plan for the future (ACD, SDM)
  • Medications review
88
Q

What are Lewy bodies?

A

Aggregates of misfolded alpha-synuclein + other proteins

89
Q

Lewy bodies are implicated in which types of dementia?

A
  • Lewy body dementia

- Parkinson disease

90
Q

State 1-2 distinguishing features of each of the following dementia subtypes:

  1. Vascular dementia
  2. Dementia with lewy bodies
  3. Parkinson dementia
  4. Frontotemporal dementia
  5. Normal pressure hydrocephalus
A
  1. VASCULAR DEMENTIA: may present with abrupt cognitive decline and stepwise deterioration. Asymmetric or focal deficits.
  2. DLB: Visual hallucinations, parkinsonian motor signs, attention impairment
  3. PARKINSON DEMENTIA: dementia onset >1 year after motor symptoms,
  4. FRONTOTEMPORAL DEMENTIA: early changes in personality, apathy
  5. NORMAL PRESSURE HYDROCEPHALUS: ‘wet, wobbly, whacky’ = urinary incontinence, gait disorder, dementia
91
Q

Describe the potential CT head findings in someone with Alzheimer disease

A
  • Reduced hippocampal volume
  • Enlarged sulci
  • Enlarged ventricles
92
Q

What is an ACAT?

A

Aged Care Assessment Team

Assesses the needs of older people and makes recommendations for government-funded care and support (e.g. home care packages)

93
Q

How could you counsel a patient who is resistant to receiving an ACAT?

A

The ACAT will help ensure that you can stay at home for longer by seeing if we can make your life at home safer and easier

It’s not being used to put you in a nursing home

94
Q

Driving difficulty is prominent in which of the common types of dementia?

Which functions have been impaired?

A

Driving difficulty is common in AD and DLB.

Due to impaired executive and visuospatial function.

YEAR 3 - SEMESTER 2 (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions